Show content

Home

Thinking Chemically to Discover New Targeted Cancer Drugs

About a third of all cancers are driven by mutations in RAS genes. Learn how NCI funding is helping Dr. Kevan Shokat develop drugs that inactivate molecular drivers of cancer such as RAS.

Media Type: Html

SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1126608.htm
Syndication ID: 19922
Language: English
Source: National Cancer Institute (NCI)
Date Syndication Captured: Monday, March 23, 2020 at 07:17 PM
Date Syndication Updated: Monday, March 23, 2020 at 07:17 PM

0 Users liked this content.

Embed Code Snippet

To get the embed code snippet please Login.